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Does low urinary sIgA predispose to urinary tract infection? Median
urinary secretory IgA (sIgA) (EL!SA technique in unprocessed urine)
was 1.36 mg/liter (range, 0.29 to 2.31) in healthy female controls at
various times of the menstrual cycle. It was significantly lower in
women with urinary tract infection (UT!) without antibody-coated
bacteria. Such decrease was found both in women with acute UT!
episodes (median, 0.16; range, 0.06 to 1.71) and in asymptomatic
nonbacteriuric women with a history of UT! (median, 0.52; range, 0.05
to 2.13). !n the latter women, sIgA in nasal secretions tended to be low,
but salivary s!gA was unchanged. Urinary s!gA was elevated signifi-
cantly in individuals with nephrostomy and antibody-coated bacteria
(14.4 mg/liter, range, 3.6 to 20). The study showed that locally synthe-
sized s!gA immunoglobulins were low in the urine of individuals with
recurrent UT! independent of the presence or absence of bacteriuria at
the time of the study. UT! per se did not interfere with s!gA secretion as
shown by high s!gA in patients with upper UT!. Low urinary s!gA may
represent one factor predisposing to recurrent UTI.
Des sIgA urinaires basses prédisposent-elles a l'infection urinaire? La
médiane des sIgA urinaires (technique ELISA sur des urines non
traitées) était de 1,36 mg/litre (extremes 0,29 a 2,3 1) chez des femmes
contrôles normales a différentes périodes du cycle menstruel. Elle était
significativement plus basse chez les femmes ayant une infection
urinaire (UTI) sans bactérie recouverte d'anticorps. Cette diminution a
été trouvée chez les femmes avec des episodes d'UTI aiguë (médiane,
0,16; extremes 0,06 a 1,71) et chez des femmes nonbacterieuriques
asymptomatiques avec une histoire d'UTI (médiane, 0,52; extremes
0,05 a 2,13). Chez ces dernières, les s!gA dessécrétions nasales
tendaient a etre basses, mais les sigA salivaires étaient inchangees. Les
sIgA urinaires étaient significativement élevées chez des sujets ayant
une néphrostomie et des bactéries recouvertes d'anticorps (14,4
mg/litre; extremes, 3,6 a 20). Cette étude montre que les immunoglobu-
lines s!gA synthétisées localement sont basses dans les urines de sujets
ayant des UTI récidivantes, indépendamment de Ia presence ou de
l'absence de bactériurie au moment de l'étude. L'UT! en soi n'interfère
pas Ia sécrétion de sIgA comme le montre les sIgA élevées chez des
malades avec des UT! du tractus supérieur. Les sigA urinaires basses
pourraient constituer un facteur prédisposant a des UT! rCcidivantes.
Bacterial adhesion to epithelial cells is a crucial event in the
initiation of urinary tract infection. In individuals with recurrent
urinary tract infections, an imbalance between factors which
promote bacteria! adhesion and factors which interfere with
bacterial adhesion are thought to condition repeated episodes of
ascending infections of the urinary tract (UT!).
Secretory IgA (sIgA), an immunoglobulin synthesized locally
in mucosal surfaces, plays a pivotal role in preventing mucosal
colonization by pathogenic bacteria [1]. This has been well
studied in the intestine [2]. A similar ro!e has been postulated
for the urinary tract, although its protective effect in this
location is less well documented.
Measurement of sIgA in biological fluids is beset with many
methodologica! problems. According to Akerlund et al [3],
consistent but variable losses of sIgA occur when urine is
concentrated or stored. Immunodiffusion methods are too in-
sensitive to permit accurate measurements of urinary sIgA.
Recently, the introduction of enzyme-linked immunosorbent
assay (ELISA) or radioimmunoassay (RIA) techniques has
permitted the measurement of sIgA in unprocessed native urine
[3—51.
In this study, sigA concentrations were examined with the
ELISA technique in urine, saliva, and nasa! secretions of
women with urinary tract infection.
Methods
Probands. As controls, 46 healthy women (median age, 26
years; range 18 to 40) without a history of urinary tract infection
were studied in various phases of the menstrual cycle. In all
female contro!s sIgA was measured in morning urine speci-
mens. In 37 of the 46 controls saliva was examined and in 20 of
the controls nasal washings were also examined. In addition,
five women (20 to 35 years) measured basal temperature and
were studied on days 4, 9, 16, and 23 of their menstrual cycle.
One of the probands used oral contraceptives and the others
took no hormonal medication. Furthermore, six healthy men,
aged 25 to 30 years, were examined.
The following patient groups were studied: (1) !3 bacteriuric
women (median age, 27 years; range, 18 to 35) with a history of
recurrent ( three episodes) urinary tract infection (UTI)
immediately after admission for dysuria within 48 hr after the
onset of symptoms prior to administration of antibiotics; six
women had subvesical narrowing, and seven had no urethra!
abnormalities; (2) nine women (median age, 26 years; range 17
to 34) with a history of recurrent UTI who had neither symp-
toms nor bacteriuria at the time of the study. In seven of these
nine women sIgA in sa!iva and nasal secretions were also
measured; (3) six women (median age, 22; range, 17 to 24)
without a history of recurrent UT! who presented with acute
dysuria and frequency without fever or flank pain; a!l had
significant bacteriuria ( !00,000/ml) and had received no
antibiotics; (4) ten individuals (seven women and three men,
759
Received for publication November 18, 1981
and in revised form October 8, 1982
© 1983 by the International Society of Nephrology
760 Riedasch ci a!
Acute episode of UT!
History of UTI, asymp-
tomatic without bacte-
riuria
No history of UT!,
symptomatic episode
with bacteriuria
Nephrostomy 10 14.4 6.7
(3.6 to 20) (2.35 to 42.5)
Abbreviation: N, number of patients or controls studied.
Significant difference between probands and controls:
a P < 0.001
P < 0.05
aged 20 to 70 years) with tube nephrostomy for greater than or
equal to 10 days and with bacteriuria and carcinoma of the
bladder (N — 5) or ureteral stones (N = 5).
Collection of urine. In both normal probands and outpatients,
morning urine was obtained using the midstream technique. In
one specimen, urine bacteriology was examined with the dip
slide technique (Uricult). Another specimen was deep frozen
(—20°C) for urinary creatinine (Technicon Autoanalyser). The
rest was used for immediate determination of sigA.
Collection of so/ha. Salivary flow was first stimulated by
pipetting 1 ml of lemon juice into the mouth of the proband.
After I mm the proband was asked to spit out all saliva.
Subsequently, a tube (PVC, ID 2 cm) with a bevelled end was
pressed tightly underneath the opening of the parotid duct.
Another milliliter of lemon juice was administered to the
tongue, and parotid saliva was collected. The specimens of
saliva were used for direct determination of sigA (ELISA) and
sodium (flame photometry).
Collection of nasal secretions. The probands were seated
with their necks hyperextended while 5ml isotonic 37°C saline
were pipetted into each nostril. The probands were then asked
to tilt their heads forward and blow through their noses. The
fluid, approximately 7 ml, was caught in a plastic container and
centrifuged (10 mm, 3000 rpm). The supranatant was used for
direct determination of sIgA.
Measurement of s/gA. Reagents: Antiserum against human
alpha chains (2.9 g ab/liter) prepared from goat was obtained
from Hyland Laboratories, Costa Mesa, California. As the sigA
standard, cooled human maternal milk was used which was
kindly provided by Dr. L. A. Hanson (Goteborg, Sweden).
The concentration was 1.2 g sIgA/liter. Rabbit anti-secretory
component (SC) was obtained from Dakopatts AS, Copenha-
gen, Denmark, and was conjugated with alkaline phosphatase
with a specific activity of 990 U/mg protein (Sigma Chemical
Company, St. Louis, Missouri). Nitrophenyl-phosphate (Sigma
Chemical Company) was used as a substrate.
sigA was measured according to Akerlund et a! [31. Plastic
tubes (55 X II mm, Heger Plastiks AB, Stallarholmen, Sweden)
were coated with 0.9 ml of a serum IgA pool (13 mg/mI) diluted
mg sigA//iter mg ,slgA/mmo/e Na
51.5 1.33
(11.8 to 200) (0.07 to 11.8)
52.8 1.26
(36.5 to 91.5) (0.18 to 5.53)
Value reflects a significant difference between probands and con-
trols (P 0.01).
1:1000 in PBS (pH 7.2) containing 3 mmoles NaN. The tubes
containing the serum IgA were rotated with a slanted rotor
driven by an electromotor at 37°C for 3 hr. Subsequently,
glutardialdehyde (0.2) was added to a final concentration of
0.02% (to cross-link the adsorbed IgA molecules) followed by
incubation of the tubes for an additional hour. The coated tubes
were stored at 4°C overnight. After the tubes had been rinsed
three times with PBS (pH 7.2), 0.5 nil antihuman IgA (Hyland
Laboratories) was added in a dilution of 1:1000 in PBS contain-
ing 0.05% 1ween 20. The tubes were incubated at 37°C using a
motor driven rotor. They were subsequently kept overnight at
+ 4°C. The coated tubes were then again rinsed three times with
PBS Tween. The samples to be quantitated were diluted 1:1 to
1:100 in PBS Tween and analyzed in duplicate.
The urine and standard samples were incuba!ed in the coated
tubes for 5 hr at room temperature using a roller drum. The
tubes were then rinsed three times with PBS Tween. The rabbit
anti-SC antiserum conjugated with alkaline phosphatase was
added to the rinsed tubes in a final concentration of 0.3 mg
enzyme/liter in PBS Tween and was allowed to react with sIgA
attached to the tubes via the anti-alpha-antiserum during incu-
bation overnight on the roller drum. sIgA was finally estimated
by measuring the enzyme activity remaining after rinsing. The
substrate para-nitrophenylphosphate in diethanolamine buffer,
I g/liter (1.0 M. pH 9.8 with 0.5 mmole MgCl2) was added. After
60 to 100 mm, the reaction was stopped by the addition of 50 d
3 M NaOH. OD was measured in a Gilford flowthrough photom-
eter at 405 nm.
From each urine specimen, a 1:1, 1:5, 1:10, 1:20, and 1:40
dilution was made. Standard curves were made with the above
sigA standard using the 1:1000 to 1:120,000 dilution. The
urinary sIgA concentration was calculated using the linear part
of the dilution curve of the standard. In recovery experiments,
95 to 105% of added standard was recovered.
The standard curve was linear down to concentrations of 0.03
mg/liter (detection threshold). Specificity of the procedure was
shown by adding immunoglobulin preparations (Behring Com-
pany, Marburg, West Germany) to the assay; IgG (0.1 to 10
mg/liter) and IgA (0.1 to 10 mg/liter) did not change urinary sIgA
measurements by more than 3 to 5%. In ten replicate
measurements of three urine samples, CV was 7.4%; duplicate
measurements for the values shown in Tables 1 and 2 differed
by no more than 12%. Values exceeding such a difference were
discarded.
Statistical procedures. All values are given as median and
range. Statistical analysis was performed with the nonparamet-
nc Mann Whitney test.
Table 1. Urinary sigA in women with urinary tract infection (UTI)
Groups
Healthy controls
mg slgA/g
N mg sIgA/liter creatinine
46 1.36 1.15
(0.29 to 2.31) (0.40 to 1.93)
13 0.16 0.62a
(0.06 to 1.71) (0.06 to 1.17)
9 0.52 0.61
(0.05 to 2.13) (0.04 to 0.92)h
Table 2. sigA of saliva and nasal secretions in asymptomatic women
with recurrent urinary tract infection (UTI)
Saliva
Control(N - 37)
UTI
(N =7)
6 0.29
(0.44 to 0.91)
0.34h
(0.10 to 1.32)
Nasal secretion
mg sigA/liter
29.3
(5.0 to 133)
6.25°
(3.3 to 7.6)
Secretory IgA in urinary tract infection 761
- 150
>
0
C
a,Q
0)0
100
50
Results
Urinary sIgA in control individuals. The urinary sIgA con-
centration in 46 healthy women is given in Table I. In six
healthy male volunteers sIgA was in a comparable range (1.6
mg/liter, 1.25 to 2.14) as in females. Five women were studied at
various phases of the menstrual cycle. As shown in Figure 1,
peak concentrations of urinary sIgA were seen on the day after
ovulation.
Urinary sigA in women with UTI. As shown in Table I,
significantly lower urinary sIgA were found in women with an
acute episode of UTI. The difference between controls and
individuals with UT! is also evident from the histogram given in
Figure 2. Similarly low sIgA were found in UT! women with (N
= 6; median, sigA 0.245 mg/liter; range, 0.13 to 1.17) and
without urethral narrowing (N = 7; median sigA 0.115; range,
0.06 to 1.71).
Low urinary sIgA were also found, however, in asymptomat-
ic women with a history of UT! without bacteriuria at the time
of the study and in women with an acute episode of bacteriuria
without a history of UTI. Increased urinary sIgA were observed
in individuals with tube nephrostomy. Antibody-coated bacte-
ria, studied as described previously [61, were absent in all
bacteriuric individuals without nephrostomy and present in all
with nephrostomy.
sIgA in saliva and nasal secretions. The sigA concentration
in saliva and nasal secretion of asymptomatic women with a
history of UTI is given in Table 2. There was no difference of
salivary sIgA concentration irrespective of the frame of refer-
ence (per liter; per mmole Na; per minute). In contrast, low
sIgA were found in nasal secretions of women with recurrent
UTI. With the exception of one control proband, there was no
overlap between values in controls and UTI patients.
0.4 0.8 1.2 1.6 2.0 2.4 mg sigA/liter
Fig. 2. Frequency distribution of urinary sIgA concentration in women
with urinary tract infection and healthy control women. In the upper
panel, 22 women with a history of UTI, either bacteriuric (N = 13) or
nonbacteriuric (N = 9) at the time of the study, were examined.
Whereas the distribution is approximately Gaussian in control women,
it is markedly skewed in women with a history of UTI.
Discussion
This study shows low urinary sigA concentrations in women
with recurrent UT! irrespective of whether they were bacteri-
uric or not at the time of the study. Women with an acute attack
of UTI without a history of UTI also had low urinary sIgA.
Given their young age, such probands may represent women
susceptible to recurrent UT! who had experienced their first
attack, but this assumption remains conjectural.
The urinary sigA concentrations of unprocessed urine found
in the present study agree with values in recent studies using
similar techniques [31 or radioimmunoassay [4]. Lower normal
values were previously reported by Kaufmann, Katz, and
200
%
100
50
4 9 16 23
Day of menstrual cycle
Fig. 1. Urinary sigA concentration and menstrual cycle. Urinary sigA
was measured at days 4, 9, 16, and 23 of the menstrual cycle. sIgA
concentration (mg/liter) on day 4 was taken as 100%.
Urinary tract infection
(N=22)
2.4 mg slgMiter
Control
(N=46)
0.4 0.8 1.2 1.6 2.0
%
50
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McIntosh [71 and Uehling and Steihm [8] and Uehling [9], but in
their studies, 24-hr urine was stored, concentrated, and exam-
ined with radial immunodiffusion. As discussed by Akerlund et
al 13], the storing and processing of urine may lead to a variable
loss of sigA. Several artefacts were considered and excluded by
appropriate procedures. First, urinary sIgA in women depend
on the phase of the cycle. The change of sigA concentration
with the menstrual cycle was much larger than the error of
replicate measurements which did not exceed 10%. However,
low urinary sigA in recurrent UTI cannot be due to the
clustering of UTI episodes at the time of menstruation, since
the episodes were distributed randomly throughout the men-
strual cycle (data not given). Artefactual lowering of urinary
sigA by water diuresis is excluded by the finding of low urinary
sIgA when factored for urinary creatinine. It is unlikely that
other proteins interfere with the assay in women with UTI,
since LC (low concentration) urinary diffusion plates for IgG
and transferrin (Behring Company) were examined routinely
and these consistently failed to show the presence of IgG or
transferrin except in individuals with nephrostomy. Finally,
consumption of sigA by urinary bacteria, for example, by
proteolytic cleavage [101, is unlikely. Seeding of urine with a
reference strain of Escherichiacoil (100,000/mI) and incubation
for 24 hr at 37°C failed to decrease sigA by more than 15%,
while the sIgA concentration of noninfected urine under the
same conditions changed by no more than 3%.
The finding of lower urinary sigA supplements previous
findings of Tuttle, Sarvas, and Koistinen [11] who observed
lower vaginal immunoglobulin A in girls with recurrent UTI
when compared to an age-matched group of controls who had
never experienced bacteriuria. Kurdydyk et al [12] found no
difference of vaginal IgA in women with recurrent UTI when
compared to controls, but this must be interpreted with caution,
since after menarche the composition of vaginal secretion
depends upon the phase of the menstrual cycle [131. More
recently, Stamey, et at [141 showed that IgA and IgG concentra-
tions are reduced in susceptible and bacteriuric women with
introital carriage of Enterohacteriaceae. Specifically, the au-
thors showed antibody coating of Enterobacteriaceae with
cervicovaginal antibody in a lower proportion of women sus-
ceptible to urinary tract infections than in control subjects
resistant to urinary tract infection.
Urinary sigA concentrations, as measured by immunodiffu-
sion, were not different between control women and women
with recurrent UTI in the study of Uehling 191. but this
technique of slgA measurement does not reliably exclude sIgA
loss as discussed by Akerlund et al [3].
The presence of low urinary sigA could be the cause or the
consequence of urinary tract infection.
It is unlikely that luminal infections (negative antibody coat-
ing) could interfere with local sIgA synthesis. First, Hand et at
[151 found no change of sIgA synthesis in experimental bladder
infections. Second, sigA levels were low in acutely symptomat-
ic urinary tract infection without antibody-coated bacteria but
consistently elevated in patients with nephrostomy and anti-
body-coated bacteria. This agrees with previous observations
of Uehling and Steihm [81 who found higher urinary sIgA in UTI
of children with severe anatomic derangements of urinary
tracts. Our experimental studies show that the mucosa of the
urinary tract caii mount a local immune response if the damaged
lamina propria is invaded by bacteria 1161. It is therefore
unlikely that low urinary sIgA in UTI are an expression of
damage to the uroepithelium.
The alternate hypothesis would be that low urinary sigA
concentrations are causally related to UTI. The role of sigA in
the genesis of UTI in our patients is difficult to evaluate because
the antigenic specificity of sIgA was not examined. However, it
is known from previous studies of Svanburg-Edén [171 that
antibodies of the sIgA class may prevent adhesion of F. colt to
human urinary tract epithelial cells. Rossen et al [18] showed
that low sIgA may predispose to mucosal infection. He found
that nasal antibody activity in response to a challenge with
influenza virus tended to be detected earlier, with symptoms
developing less frequently, in those individuals who had higher
baseline concentrations of IgA in nasal wash specimens. Since
low urinary sigA were also found in patients with a history of
UTI but without demonstrable bacteriuria at the time of the
study, it is conceivable that low sIgA may predispose to
colonization of the urinary tract mucosa by pathogenic bacteria.
In this context it is intriguing that in women with recurrent
UTI sIgA in nasal secretions, but not in saliva, was low in
parallel with low urinary sIgA. Although statistically signifi-
cant, this result must be interpreted with caution because the
sample size was small. The finding would be consistent, howev-
er, with the hypothesis that low urinary sIgA is a reflection of a
more general mucosal defect. This hypothesis requires confir-
mation by further studies involving more patients and additional
mucosal secretions.
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